Interestingly, in digestive system cancers, such as esophageal adenocarcinoma, pancreatic cancer, colorectal cancer or cholangiocarcinoma, GATA6 could be used as a prognostic tumor marker for different mechanisms52–55. This evidence concerns the gene GATA6 and pancreatic neoplasm.